Literature DB >> 21414994

Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.

Emanuele Zurolo1, Anand Iyer, Mattia Maroso, Caterina Carbonell, Jasper J Anink, Teresa Ravizza, Kees Fluiter, Wim G M Spliet, Peter C van Rijen, Annamaria Vezzani, Eleonora Aronica.   

Abstract

Recent evidence in experimental models of seizures and in temporal lobe epilepsy support an important role of high-mobility group box 1 and toll-like receptor 4 signalling in the mechanisms of hyperexcitability leading to the development and perpetuation of seizures. In this study, we investigated the expression and cellular distribution of toll-like receptors 2 and 4, and of the receptor for advanced glycation end products, and their endogenous ligand high-mobility group box 1, in epilepsy associated with focal malformations of cortical development. Immunohistochemistry showed increased expression of toll-like receptors 2 and 4 and receptor for advanced glycation end products in reactive glial cells in focal cortical dysplasia, cortical tubers from patients with the tuberous sclerosis complex and in gangliogliomas. Toll-like receptor 2 was predominantly detected in cells of the microglia/macrophage lineage and in balloon cells in focal cortical dysplasia, and giant cells in tuberous sclerosis complex. The toll-like receptor 4 and receptor for advanced glycation end products were expressed in astrocytes, as well as in dysplastic neurons. Real-time quantitative polymerase chain reaction confirmed the increased receptors messenger RNA level in all pathological series. These receptors were not detected in control cortex specimens. In control cortex, high-mobility group box 1 was ubiquitously detected in nuclei of glial and neuronal cells. In pathological specimens, protein staining was instead detected in the cytoplasm of reactive astrocytes or in tumour astrocytes, as well as in activated microglia, predictive of its release from glial cells. In vitro experiments in human astrocyte cultures showed that nuclear to cytoplasmic translocation of high-mobility group box 1 was induced by interleukin-1β. Our findings provide novel evidence of intrinsic activation of these pro-inflammatory signalling pathways in focal malformations of cortical development, which could contribute to the high epileptogenicity of these developmental lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414994     DOI: 10.1093/brain/awr032

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  64 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

2.  Anti-proliferative effect and cell cycle arrest induced by saponins extracted from tea (Camellia sinensis) flower in human ovarian cancer cells.

Authors:  Yaomin Wang; Ning Ren; Gary O Rankin; Bo Li; Yon Rojanasakul; Youying Tu; Yi Charlie Chen
Journal:  J Funct Foods       Date:  2017-08-10       Impact factor: 4.451

Review 3.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 4.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

5.  Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation.

Authors:  Avanita S Prabowo; Jasper J Anink; Martin Lammens; Mark Nellist; Ans M W van den Ouweland; Homa Adle-Biassette; Harvey B Sarnat; Laura Flores-Sarnat; Peter B Crino; Eleonora Aronica
Journal:  Brain Pathol       Date:  2012-08-30       Impact factor: 6.508

6.  Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction.

Authors:  Jaclyn M Schwarz; Staci D Bilbo
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 7.  Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.

Authors:  Annamaria Vezzani; Rosaria Pascente; Teresa Ravizza
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

Review 8.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

9.  Expression Patterns of TRPC1 in Cortical Lesions from Patients with Focal Cortical Dysplasia.

Authors:  Zhenle Zang; Song Li; Wei Zhang; Xin Chen; Dahai Zheng; Haifeng Shu; Wei Guo; Bangyun Zhao; Kaifeng Shen; YuJia Wei; Xin Zheng; Shiyong Liu; Hui Yang
Journal:  J Mol Neurosci       Date:  2015-08-18       Impact factor: 3.444

10.  Differential seizure response in two models of cortical heterotopia.

Authors:  Lisa A Gabel; Monica Manglani; Natalia Ibanez; Jessica Roberts; Raddy L Ramos; Glenn D Rosen
Journal:  Brain Res       Date:  2012-11-29       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.